Dr. Mikhail Blagosklonny and His War on Cancer

Dr. Mikhail Blagosklonny has made a career of fighting the ever present cancer that has afflicted humanity since the first person drew breath. Currently, Dr. Blagosklonny is a professor of Oncology at the Rosewell Park Cancer Institute in Buffalo, New York, and editor-in-chief for Oncotarget, where he has done incredible work and research concerning aging.He is renowned for discovering another usage of Rapamycin, a drug traditionally used to prevent the body’s rejection of organ transplants: increasing a common human’s lifespan. It has obviously been used to treat cancer, but it can be used in countless other ways to halt the onset of aging complications every human has ever experienced. Besides preventing a patients organs from rejecting a foreign organ, Rapamycin, also known as Sirolimus, is great for treating patients with hemolytic-uremic syndrome, where your kidneys fail, you’re anemic and your platelet count is low.

Rapamycin prevents the transplanted kidney, essential for survival, from contracting the disease. Rapamycin also treats a wordy lung disease called Lymphangioleiomyomatosis; Rapamycin keeps it from growing and spreading, making it easier to treat. A major medical advancement Rapamycin permits is a quality treatment of cancer; it can promote tumor regression and boosts your immuno-response to the tumor. As the list continues, it becomes clear that Rapamycin is an important find; from Alzheimer’s and Muscular Dystrophy, to LSE, TSC and Facial angiofibromas. But Dr. Blagoskonny is hard at work researching how it can increase the longevity of a person, having tested Rapamycin on mice with tuberculosis. He is set to test it on the Mamoset monkey next.As one might see, Dr. Mikhail Blagosklonny is passionate in his work with oncology.

He believes that medical research can be applied to increase the lives of humans world wide, connecting it to his field of oncology as well as the subject of aging. He is a researcher, professor and philanthropist, and is intent on changing the face of oncology, from the treat-the-symptom mindset to the treat-the-disease one. He continues to conduct his research, his heart driving his Samaritan’s work, while also inspiring the students he teaches and his peers, influencing the medical profession from the floor up.He is digging deep to find a cure for cancer, but not on the beaten path of the rest of his colleagues; he is working hard to find a cure that is not nearly as excruciating or financially burden-some as the so-called cures that have been developed up until this point. He seeks to lead the way in this path, and hopes that others in his field will take up the task so that, one day, a treatment for cancer can be easy and inexpensive, brightening the future of humanity and the health of our posterity.

Leave a Reply

Your email address will not be published. Required fields are marked *